Olanzapine - Behavioural and Psychological Symptoms of Dementia
You are here : Home > Formulary Search > Olanzapine - Behavioural and Psychological Symptoms of Dementia
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Oro-dispersible tablets
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Initiation by a mental health specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.
PAD Profile
ChemicalSubstance :
Olanzapine
Indication :
Behavioural and Psychological Symptoms of Dementia
Group Name :
Keywords :
BPSD, dementia, aggression, Non-cognitive symptoms of dementia
Alzheimer's Disease, aggression, antipsychotics, anticholinergic burden
Brand Names Include :
Zyprexa
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Olanzapine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Behavioural and Psychological Symptoms of Dementia.
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated resource pack for use by primary care prescribers for managing non-cognitive symptoms in people living with dementia.
GENERIC Olanzapine has been considered by the PCN and has been assigned a BLUE traffic light status
NOTE - the branded product, Zyprexa, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Zyprexa, was considered BLACK at the PCN in May 2017.